Pediatrix Medical Group (MD) Stock Forecast & Price Target

MD price $29.05 +0.14 +0.48%

Ticker
MD
Price
$29.05
Change
+0.14 +0.48%
Market cap ?
$2.36B
P/E ?
13.70
Forward P/E ?
12.37
Dividend yield ?
0.00%
Beta ?
0.61
Sector
Healthcare
Industry
Medical - Care Facilities
Stocklytics score
57
Value
62
Quality
60
Growth
48

Stocklytics score rationale: value 62, quality 60, growth 48.

Financials

2016201720182019202020212022202320242025
3183159000345831200036471230001779759000173395100019111910001972021000199464000020129190001913849000

Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix…

Forecast

Consensus Hold from 7 analysts. Average price target $26.60, -8.4% versus the current price. Low $24.00. High $28.00.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Analysts have an average 12-month price target of $26.60 for Pediatrix Medical Group (MD), 8.4% below the current price of $29.05. Of 7 analysts covering the stock, 1 rate it Buy or Strong Buy, 6 Hold, and 0 Sell or Strong Sell, giving a consensus of Hold.

Forecasts are third-party estimates and often wrong. They are not investment advice.

MD price target

12-month price target
Low$24.00
Average$26.60
High$28.00

The average is 8.4% below the current price of $29.05.

Is Pediatrix Medical Group a buy or sell?

Of 7 analysts, 1 rate Pediatrix Medical Group Buy or Strong Buy, 6 Hold, and 0 Sell or Strong Sell. The consensus label is Hold. That split is not a recommendation.

Pediatrix Medical Group earnings and revenue forecast

Analyst averages on file: 2026, EPS $2.35, revenue $1.96 billion. 2027, EPS $2.44, revenue $2.01 billion.

MD score and fair value

The Stocklytics Score for MD is 57 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.

MD forecast FAQs

What is the MD price target?

$26.60 average, with a published range of $24.00 to $28.00.

Is Pediatrix Medical Group a buy or sell?

The consensus is Hold from 7 analysts. This is not a recommendation.

What is the Pediatrix Medical Group stock forecast for 2026?

Analysts' average EPS estimate for 2026 on file is $2.35. The average revenue estimate is $1.96 billion.

What will MD be worth in 2030?

No reliable forecast exists that far out.

When is Pediatrix Medical Group's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Pediatrix Medical Group (MD) Stock Forecast & Price Target

MD$29.05+0.14 +0.48%

$2.36B

Market Cap

13.70

P/E

12.37

Forward P/E

57

Score

Price History